Princeton, N.J.
WIRB-Copernicus Group (WCG), a global provider of regulatory and ethical review services for clinical research, acquired Alliance Biosciences in July of 2014. With this addition, WCG Biosafety will be able to manage the entire continuum of biocontainment oversight, helping to ensure that research involving potentially hazardous agents and vectors complies with the appropriate regulatory requirements from laboratory design and drug discovery through clinical testing and therapeutic application. WCG Biosafety currently manages more than 200 Institutional Biosafety Committees (IBCs) and has evaluated more than 140 gene transfer clinical and recombinant DNA pre-clinical research protocols to date.
